investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
CRC Tier 1 - Biological networks in human health and disease
Michael Tyers
0 Collaborator(s)
Funding source
Canadian Institutes of Health Research (CIHR)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Michael Tyers
University of Montreal
Montreal, Canada
Related projects
Fang Wang
Defining the role of human isomiR-181a in myelodysplastic syndromes
All cancers but non-melanoma skin cancer
Melanoma of skin
Akil Hamza
Human complementation of yeast mutations to identify candidate cancer therapeutic targets
All cancers but non-melanoma skin cancer
Melanoma of skin
Christopher A French
Pathogenesis and Treatment of NUT-Midline Carcinoma
All cancers but non-melanoma skin cancer
Denis C Guttridge
Second Cancer Cachexia Conference: Evolving Mechanisms and Therapies
All cancers but non-melanoma skin cancer
Ashish Lal
Comparative Oncology program
All cancers but non-melanoma skin cancer
Jeffrey Wrana
qTAP, A Novel Platform for Personalized Medicine in Cancer
All cancers but non-melanoma skin cancer
Melanoma of skin
Chantal Guillemette
Pharmacogenomics program identifies genomic changes that affect adverse effects and treatment efficacy (CANADA RESEARCH CHAIRHOLDER - Tier 1)
All cancers but non-melanoma skin cancer
Melanoma of skin
Shun-Cheng Li
Identification of protein-protein interactions and the resultant signaling networks (CANADA RESEARCH CHAIRHOLDER)
All cancers but non-melanoma skin cancer
Melanoma of skin
James Dennis
The role of Tudor domain proteins in normal development and cancer
All cancers but non-melanoma skin cancer
Melanoma of skin